Recent Updates
Recently added Catalysts
INM

Burrard St, 3rd Floor Vancouver Date

Key Takeaway: 510 Burrard St, 3rd Floor Vancouver Date: October 27, 2021 BC, V6C 3B9 www.computershare.com To: All Canadian Securities Regulatory Authorities Subject: INMED PHARMACEUTICALS INC. We advise of the following with respect to the upcoming Meeting of Security Holders for the su

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~6 mo
High dilution risk
Lead asset
INM-755
Phase 2 · Epidermolysis Bullosa Simplex

Full Press Release Details

510 Burrard St, 3rd Floor Vancouver
Date: October 27, 2021 BC, V6C 3B9
www.computershare.com
To: All Canadian Securities Regulatory Authorities
Subject: INMED PHARMACEUTICALS INC.
We advise of the following with respect to the upcoming Meeting
of Security Holders for the subject Issuer:
Meeting Type : Annual General Meeting
Record Date for Notice of Meeting : October 28, 2021
Record Date for Voting (if applicable) : October 28, 2021
Beneficial Ownership Determination Date : October 28, 2021
Meeting Date : December 17, 2021
Meeting Location (if available) : Vancouver, BC
Issuer sending proxy related materials directly to NOBO: Yes
Issuer paying for delivery to OBO: No
Notice and Access (NAA) Requirements:
NAA for Beneficial Holders Yes
Beneficial Holders Stratification Criteria: Not Applicable
NAA for Registered Holders Yes (AMENDED)
Registered Holders Stratification Criteria: Not Applicable (AMENDED)
Voting Security Details:
Description CUSIP Number ISIN
COMMON CLASS 457637502 CA4576375022
Agent for INMED PHARMACEUTICALS INC.
Last updated: Oct 27, 2021